Author | Ilya Petrou. M.D.


New device treats nonmelanoma skin cancer

June 04, 2020

A new energy-based device delivering ultrafast pulses of high amplitude electrical energy to nonthermally preferentially clear targeted cell rich lesions is proving to be a very useful treatment modality for a number of benign dermatologic lesions.

Systemic antibiotics impact skin microbiota in rosacea patients

June 02, 2020

A recent study published in the Journal of Clinical Medicine evaluated the changes seen in the skin’s microbiota of patients following antibiotic therapy to elucidate which organisms might play the biggest role in development of rosacea symptoms.

Potential first-line treatment for advanced cutaneous squamous cell carcinoma

May 22, 2020

The epidermal growth factor (EGFR) inhibitor cetuximab achieved good outcomes in patients with advanced SCC, according to results of a recent study.

Immunotherapy for advanced squamous cell carcinoma

May 12, 2020

Immunotherapeutic agents have become an important treatment option for patients with advanced squamous cell carcinoma

Mast cells may play key role in rosacea pathogenesis

May 06, 2020

Mast cells appear to play an intricate role in the pathophysiology of rosacea and could serve as potential targets for future therapies, according to recent study findings.

The future of actinic keratosis treatment

May 04, 2020

It is estimated that 0.025% to 16% of all actinic keratosis (AK) lesions may progress into invasive SCC per year, and there is still no marker to predict which lesions will progress, according to a recent paper that outlined diagnostic challenges as well as current and pipeline treatment approaches.

Pipeline treatments show promise for acne patients

April 22, 2020

Hilary E. Baldwin, M.D. discusses advances in acne treatment that have expanded treatment options, allowing physicians to improve outcomes in patients with moderate-to-severe acne.

A paradigm shift in squamous cell carcinoma treatment

March 30, 2020

Recent advances in systemic therapies have led to the development of PD-1 checkpoint inhibitors, which one expert says may represent a paradigm shift in the treatment and management of patients with locally advanced or metastatic cutaneous squamous cell carcinoma (SCC).

Expert discusses hair loss treatment controversies, concerns

March 26, 2020

It is important for clinicians to stay abreast with the latest data coming out of trials and individually consult their hair loss patients accordingly on a case by case basis, says this expert.

Targeted therapies for advanced basal cell carcinoma

March 26, 2020

Continued research has produced a number of targeted therapies that provide hope for patients with this rare but sometimes deadly form of nonmelanoma skin cancer.